We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Serious Complications Rare in Carpal Tunnel Surgery

By HospiMedica International staff writers
Posted on 12 Nov 2020
Carpal tunnel decompression surgery rarely results in serious complications or need for reoperations, according to a new study.

Researchers at the University of Oxford (Oxford; United Kingdom) conducted a UK nationwide cohort analysis of all carpal tunnel decompression surgeries held in adult patients between April 1, 1998, and March 31, 2017, using the Hospital Episode Statistics dataset; patients were followed-up until death or the end of the study. More...
The primary outcomes were overall incidence of carpal tunnel decompression reoperation and serious postoperative complications, including surgical site infection (SSI), dehiscence, and neurovascular or tendon injury requiring admission to hospital.

In all, 855,832 carpal tunnel decompression surgeries were performed, with 3.42% of them leading to reoperations. But just 0.07% of the procedures led to serious complication within 30 days after surgery, and just 0.082% within 90 days. Local complications were associated with male sex and patients 18 to 29 years of age; Male sex, age over 80 years at index procedure, and greater levels of comorbidity and socioeconomic deprivation were associated with increased reoperation risk. The study was published on September 30, 2020, in The Lancet Rheumatology.

“To our knowledge, this is the largest national study on carpal tunnel decompression to date, providing strong evidence on serious postoperative complication and reoperation rates,” concluded lead author Jennifer Lane, MD, of the Oxford Nuffield Orthopaedic Centre. “Carpal tunnel decompression appears to be a safe operation in most patients, with an overall serious complication rate requiring admission to hospital or further surgery of less than 0.1%.”

Carpal tunnel syndrome is an idiopathic neuropathy of the median nerve inside the carpal tunnel. The main symptom is an intermittent numbness of the thumb, index, long and radial half of the ring finger, which usually occurs at night and is relieved by wearing a wrist splint to prevent flexion. Long-standing neuropathy leads to permanent nerve damage with constant numbness, atrophy of some of the muscles of the thenar eminence, and weakness of palmar abduction; risk factors are primarily genetic, rather than environmental.

Related Links:
University of Oxford


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Medical Cart
Medical Carts
New
Intelligent Mattress System
DualPlus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The principle of needle-free injection based on the reflection of shock waves through microbubble dynamics (Photo courtesy of Yibo Ma/Kyushu University)

Novel Needle-Free Reagent Injection Method to Reduce Spread of Infectious Diseases

Currently, drug administration for disease treatment and prevention commonly uses injectors with metal needles. However, as the needle directly contacts the patient’s mucus and blood, the use of different... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.